Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.06
-0.46 (-1.67%)
At close: Apr 28, 2026, 4:00 PM EDT
27.00
-0.06 (-0.22%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Assembly Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 72.3 | 28.52 | 7.16 | - | 6.25 | |
| Revenue Growth (YoY) | 153.52% | 298.16% | - | - | -92.09% | |
| Cost of Revenue | 64.81 | 55.93 | 48.9 | 69.08 | 70.15 | |
| Gross Profit | 7.49 | -27.41 | -41.74 | -69.08 | -63.9 | |
| Selling, General & Admin | 19.61 | 18.01 | 22.91 | 23.93 | 28.5 | |
| Operating Expenses | 19.61 | 18.01 | 22.91 | 23.93 | 28.5 | |
| Operating Income | -12.12 | -45.42 | -64.65 | -93.01 | -92.4 | |
| Interest & Investment Income | 6 | 5.57 | 3.45 | 1.02 | 0.3 | |
| EBT Excluding Unusual Items | -6.12 | -39.85 | -61.2 | -91.99 | -92.1 | |
| Merger & Restructuring Charges | - | - | - | -1.1 | 1.35 | |
| Impairment of Goodwill | - | - | - | - | -12.6 | |
| Asset Writedown | - | - | - | - | -0.04 | |
| Pretax Income | -6.12 | -39.85 | -61.2 | -93.09 | -132.39 | |
| Income Tax Expense | - | 0.33 | 0.03 | - | -2.53 | |
| Net Income | -6.12 | -40.18 | -61.23 | -93.09 | -129.86 | |
| Net Income to Common | -6.12 | -40.18 | -61.23 | -93.09 | -129.86 | |
| Shares Outstanding (Basic) | 11 | 6 | 5 | 4 | 4 | |
| Shares Outstanding (Diluted) | 11 | 6 | 5 | 4 | 4 | |
| Shares Change (YoY) | 86.71% | 31.18% | 13.47% | 11.85% | 22.17% | |
| EPS (Basic) | -0.55 | -6.69 | -13.38 | -23.08 | -36.00 | |
| EPS (Diluted) | -0.55 | -6.69 | -13.38 | -23.08 | -36.00 | |
| Free Cash Flow | -41.16 | -51.15 | 22.49 | -84.57 | -96.49 | |
| Free Cash Flow Per Share | -3.67 | -8.52 | 4.91 | -20.96 | -26.75 | |
| Gross Margin | 10.36% | -96.12% | - | - | - | |
| Operating Margin | -16.76% | -159.26% | -902.50% | - | -1477.42% | |
| Profit Margin | -8.47% | -140.87% | -854.78% | - | -2076.35% | |
| Free Cash Flow Margin | -56.93% | -179.33% | 313.95% | - | -1542.88% | |
| EBITDA | -11.99 | -45.29 | -64.2 | -92.52 | -91.93 | |
| EBITDA Margin | -16.58% | -158.80% | - | - | - | |
| D&A For EBITDA | 0.13 | 0.13 | 0.45 | 0.5 | 0.47 | |
| EBIT | -12.12 | -45.42 | -64.65 | -93.01 | -92.4 | |
| EBIT Margin | -16.76% | -159.26% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.